First Header Logo Second Header Logo

Stephen Tatter

Concepts (375)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Radiosurgery
61
2020
356
7.750
Why?
Brain Neoplasms
69
2021
638
6.980
Why?
Neoplasm Recurrence, Local
21
2020
370
2.260
Why?
Glioma
15
2021
136
1.890
Why?
Meningioma
10
2020
57
1.480
Why?
Trigeminal Neuralgia
9
2019
33
1.330
Why?
Meningeal Neoplasms
8
2017
49
1.270
Why?
Middle Aged
86
2020
11827
1.220
Why?
Retrospective Studies
49
2020
3523
1.210
Why?
Laser Therapy
6
2020
55
1.200
Why?
Treatment Outcome
45
2020
3313
1.190
Why?
Glioblastoma
12
2020
156
1.120
Why?
Salvage Therapy
16
2020
134
1.090
Why?
Adult
67
2020
9346
1.060
Why?
Aged
69
2020
10318
1.050
Why?
Female
91
2020
19969
0.990
Why?
Humans
112
2020
32004
0.980
Why?
Male
84
2020
19169
0.960
Why?
Parkinson Disease
9
2020
82
0.910
Why?
Intracranial Arteriovenous Malformations
3
2012
21
0.840
Why?
Deep Brain Stimulation
8
2020
49
0.830
Why?
Antineoplastic Agents, Alkylating
5
2018
40
0.820
Why?
Magnetic Resonance Imaging
18
2018
1328
0.810
Why?
Negative-Pressure Wound Therapy
4
2016
36
0.760
Why?
Cerebellar Neoplasms
2
2019
11
0.750
Why?
Drug Delivery Systems
5
2021
104
0.750
Why?
Postoperative Complications
6
2019
784
0.750
Why?
Follow-Up Studies
26
2020
2277
0.740
Why?
Antineoplastic Agents
9
2020
608
0.740
Why?
Aged, 80 and over
33
2020
3995
0.700
Why?
Cranial Irradiation
9
2020
93
0.700
Why?
Brain
6
2015
951
0.700
Why?
Hemangioblastoma
1
2019
4
0.660
Why?
von Hippel-Lindau Disease
1
2019
5
0.660
Why?
Neurosurgical Procedures
4
2015
99
0.580
Why?
Carmustine
3
2015
8
0.570
Why?
Combined Modality Therapy
11
2018
564
0.570
Why?
Dura Mater
2
2012
14
0.510
Why?
Stereotaxic Techniques
5
2020
23
0.500
Why?
Convection
3
2021
8
0.490
Why?
Treatment Failure
12
2020
163
0.470
Why?
Young Adult
17
2020
2638
0.460
Why?
Corpus Striatum
3
2020
60
0.450
Why?
Radiotherapy
6
2018
82
0.440
Why?
Disease-Free Survival
10
2020
319
0.420
Why?
Craniocerebral Trauma
1
2012
56
0.410
Why?
Subthalamic Nucleus
5
2020
13
0.400
Why?
Facial Pain
5
2014
21
0.390
Why?
Radiotherapy, Adjuvant
3
2017
77
0.380
Why?
Genetic Vectors
2
2010
120
0.370
Why?
Survival Analysis
14
2020
487
0.370
Why?
Melanoma
6
2019
164
0.360
Why?
Multiple Sclerosis
3
2019
59
0.360
Why?
Survival Rate
11
2020
885
0.350
Why?
Serotonin
2
2020
37
0.340
Why?
Anticonvulsants
1
2009
65
0.330
Why?
Radiation Injuries
5
2018
75
0.330
Why?
Lung Neoplasms
5
2017
410
0.320
Why?
Radiotherapy Dosage
9
2017
101
0.300
Why?
Nomograms
4
2017
32
0.300
Why?
Neoplasms
4
2020
724
0.290
Why?
Adolescent
11
2020
3540
0.290
Why?
Dopamine
3
2020
232
0.290
Why?
Decision Making
2
2020
195
0.290
Why?
Prognosis
10
2020
1503
0.280
Why?
Hypothalamo-Hypophyseal System
4
2008
31
0.280
Why?
Brain Edema
4
2014
15
0.270
Why?
Surgery, Computer-Assisted
4
2017
53
0.270
Why?
Child
8
2020
2436
0.260
Why?
Thalamus
2
2015
33
0.240
Why?
Glutamate Decarboxylase
2
2017
17
0.240
Why?
Postural Balance
1
2016
181
0.230
Why?
Benzenesulfonates
1
2003
3
0.230
Why?
Iodine Radioisotopes
1
2003
16
0.230
Why?
Brachytherapy
1
2003
24
0.220
Why?
Pesticides
1
2016
199
0.220
Why?
Catheterization
1
2003
58
0.220
Why?
Occupational Exposure
1
2016
232
0.220
Why?
Central Nervous System Neoplasms
2
2014
29
0.210
Why?
Transients and Migrants
1
2016
290
0.210
Why?
Emigrants and Immigrants
1
2016
244
0.210
Why?
Neurons
3
2015
410
0.210
Why?
Adenocarcinoma
2
2017
312
0.210
Why?
Brain Injuries
2
2014
93
0.210
Why?
Radiotherapy Planning, Computer-Assisted
2
2012
28
0.210
Why?
Cerebral Angiography
2
2012
60
0.200
Why?
Breast Neoplasms
4
2017
768
0.200
Why?
Carcinoma, Squamous Cell
2
2013
154
0.190
Why?
Astrocytoma
3
2018
29
0.190
Why?
Receptor, EphA2
1
2021
13
0.190
Why?
Radiation Dosage
5
2020
84
0.180
Why?
Sulfones
1
2020
21
0.180
Why?
Genomics
2
2018
85
0.180
Why?
Indans
1
2020
31
0.180
Why?
Basic Helix-Loop-Helix Transcription Factors
1
2020
46
0.180
Why?
Registries
2
2020
298
0.180
Why?
Arnold-Chiari Malformation
2
2010
8
0.180
Why?
Neoplasm Metastasis
2
2018
221
0.180
Why?
Brain Diseases
1
2020
38
0.170
Why?
Craniotomy
3
2017
46
0.170
Why?
Carcinoma
1
2020
92
0.170
Why?
Hydrocortisone
4
2008
57
0.170
Why?
Visual Perception
1
2020
116
0.170
Why?
Hispanic Americans
1
2016
940
0.170
Why?
Trigeminal Nerve
2
2010
5
0.170
Why?
Pain Measurement
4
2014
351
0.160
Why?
Movement Disorders
2
2010
26
0.160
Why?
Reward
2
2018
64
0.160
Why?
Prospective Studies
7
2019
2280
0.160
Why?
Costs and Cost Analysis
1
2018
99
0.160
Why?
Feedback, Psychological
1
2018
6
0.150
Why?
Multivariate Analysis
6
2018
687
0.150
Why?
Pituitary Gland
2
2008
9
0.150
Why?
Disease Management
2
2017
126
0.150
Why?
Cohort Studies
5
2019
1821
0.150
Why?
Glomus Jugulare Tumor
1
2017
4
0.150
Why?
Basal Ganglia
2
2014
15
0.150
Why?
Neoplastic Stem Cells
1
2018
99
0.140
Why?
Brain Death
2
2017
27
0.140
Why?
Nervous System Neoplasms
1
2017
8
0.140
Why?
Medicare
1
2018
207
0.140
Why?
Weight Gain
2
2015
117
0.140
Why?
Time Factors
7
2017
2152
0.140
Why?
Signal Transduction
1
2020
682
0.140
Why?
Gastrointestinal Neoplasms
1
2017
33
0.140
Why?
Catheters, Indwelling
2
2009
43
0.140
Why?
Immunotherapy
1
2016
81
0.140
Why?
Imaging, Three-Dimensional
1
2016
132
0.130
Why?
Spinal Cord Injuries
1
2016
39
0.130
Why?
Animals
11
2021
7542
0.130
Why?
Tremor
1
2015
11
0.130
Why?
Gene Transfer Techniques
2
2017
63
0.130
Why?
Risk Factors
7
2019
3872
0.130
Why?
Retreatment
3
2016
41
0.130
Why?
Drug Implants
1
2015
9
0.130
Why?
Ganglioglioma
1
2015
6
0.130
Why?
Urinary Bladder Neoplasms
1
2018
192
0.130
Why?
Hypesthesia
2
2015
9
0.130
Why?
Central Nervous System Diseases
1
2015
13
0.130
Why?
Neurofibromatosis 2
1
2015
5
0.130
Why?
Recombinant Fusion Proteins
3
2003
105
0.120
Why?
Carcinoma, Renal Cell
2
2017
114
0.120
Why?
Proportional Hazards Models
5
2015
756
0.120
Why?
Choice Behavior
1
2015
87
0.120
Why?
Radiotherapy, Intensity-Modulated
2
2014
34
0.120
Why?
Meningeal Carcinomatosis
1
2014
7
0.120
Why?
Brain Stem Neoplasms
1
2014
4
0.120
Why?
Incidence
4
2020
1198
0.120
Why?
Sheep
4
2008
233
0.120
Why?
Kidney Neoplasms
2
2017
201
0.120
Why?
Exotoxins
2
2003
13
0.110
Why?
Diphtheria Toxin
2
2003
26
0.110
Why?
Epidermal Growth Factor
2
2003
27
0.110
Why?
Interleukin-13
2
2003
28
0.110
Why?
Vein of Galen Malformations
1
2013
4
0.110
Why?
Carcinoma, Small Cell
1
2013
25
0.110
Why?
Cerebral Veins
1
2013
12
0.110
Why?
Smoking
1
2017
496
0.110
Why?
Tomography, X-Ray Computed
3
2014
920
0.110
Why?
Tumor Burden
4
2014
60
0.110
Why?
Influenza Vaccines
1
2014
78
0.110
Why?
Cerebral Cortex
1
2014
126
0.110
Why?
Skull Base Neoplasms
1
2012
4
0.110
Why?
Dose-Response Relationship, Radiation
4
2015
81
0.110
Why?
Spin Labels
1
2012
24
0.110
Why?
Fatal Outcome
1
2012
83
0.110
Why?
Radiotherapy, Computer-Assisted
1
2012
3
0.110
Why?
Neoplasms, Radiation-Induced
1
2012
13
0.110
Why?
Carcinoma, Basal Cell
1
2012
26
0.100
Why?
Scalp
1
2012
38
0.100
Why?
Skull
1
2012
48
0.100
Why?
Neurilemmoma
1
2012
16
0.100
Why?
Nitrogen Mustard Compounds
1
2012
4
0.100
Why?
Neoplasm Staging
3
2015
456
0.100
Why?
Small Cell Lung Carcinoma
1
2012
17
0.100
Why?
Arginine Vasopressin
2
2008
3
0.100
Why?
Lymphoma, Non-Hodgkin
1
2012
22
0.100
Why?
Procarbazine
1
2011
5
0.100
Why?
Resuscitation
1
2012
65
0.100
Why?
Collagen Diseases
1
2011
5
0.100
Why?
Angiogenesis Inhibitors
1
2011
36
0.100
Why?
Thalidomide
1
2011
31
0.100
Why?
Hyperthermia, Induced
1
2014
246
0.100
Why?
Double-Blind Method
3
2020
525
0.090
Why?
Disease Progression
3
2018
593
0.090
Why?
Viruses
1
2010
3
0.090
Why?
Medulloblastoma
1
2010
7
0.090
Why?
Algorithms
1
2014
492
0.090
Why?
Vascular Diseases
1
2011
66
0.090
Why?
Blood-Brain Barrier
1
2010
48
0.090
Why?
Radiation Oncology
1
2010
10
0.090
Why?
Posture
1
2010
54
0.090
Why?
Lymphoma
1
2010
35
0.090
Why?
Deglutition Disorders
1
2010
51
0.090
Why?
Fetus
3
2008
86
0.090
Why?
Age Factors
1
2013
1189
0.090
Why?
Cognition Disorders
1
2013
385
0.080
Why?
Case-Control Studies
2
2016
894
0.080
Why?
Cell Line, Tumor
3
2020
726
0.080
Why?
North Carolina
3
2016
1514
0.080
Why?
Cell Proliferation
3
2020
604
0.080
Why?
Neurofibromatoses
1
2008
2
0.080
Why?
Recurrence
3
2015
265
0.080
Why?
Mice, Nude
2
2020
291
0.080
Why?
Ablation Techniques
2
2018
26
0.080
Why?
Randomized Controlled Trials as Topic
1
2010
510
0.080
Why?
Databases, Factual
2
2020
353
0.070
Why?
Guanine
1
2007
15
0.070
Why?
Inositol 1,4,5-Trisphosphate
1
2006
6
0.070
Why?
Cobalt Radioisotopes
1
2006
3
0.070
Why?
Pregnancy, Animal
1
2006
19
0.070
Why?
Child, Preschool
3
2020
1268
0.070
Why?
Weight Loss
1
2010
480
0.070
Why?
Gestational Age
4
2008
120
0.070
Why?
Karnofsky Performance Status
2
2018
11
0.070
Why?
Receptors, Corticotropin
1
2005
2
0.060
Why?
Adrenal Glands
1
2005
4
0.060
Why?
Supratentorial Neoplasms
1
2004
3
0.060
Why?
Swine
2
2016
215
0.060
Why?
Fetal Development
1
2004
26
0.060
Why?
Adenoviridae
1
2004
66
0.060
Why?
Transforming Growth Factor alpha
1
2003
4
0.060
Why?
DNA Methylation
2
2015
140
0.060
Why?
Cause of Death
2
2015
238
0.060
Why?
Pituitary Gland, Anterior
1
2003
2
0.060
Why?
Hypothalamus
1
2003
17
0.050
Why?
Sheep, Domestic
1
2003
18
0.050
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2007
461
0.050
Why?
Renin-Angiotensin System
1
2004
179
0.050
Why?
Mice
2
2020
2485
0.050
Why?
Adrenocorticotropic Hormone
3
2008
19
0.050
Why?
Equipment Design
1
2003
171
0.050
Why?
Analysis of Variance
2
2017
463
0.050
Why?
Pregnancy
4
2008
996
0.050
Why?
Intracranial Hemorrhages
2
2013
33
0.050
Why?
Feasibility Studies
1
2003
294
0.050
Why?
Quality of Life
3
2018
946
0.050
Why?
Rats, Sprague-Dawley
2
2016
743
0.050
Why?
Disease Models, Animal
2
2016
1022
0.050
Why?
Cytotoxins
1
2021
13
0.050
Why?
Dogs
1
2021
120
0.050
Why?
Dyskinesias
1
2020
3
0.050
Why?
Prevalence
2
2014
981
0.050
Why?
Xenograft Model Antitumor Assays
1
2020
115
0.040
Why?
Rats
2
2016
1596
0.040
Why?
Photic Stimulation
1
2020
158
0.040
Why?
Cell Movement
1
2020
169
0.040
Why?
Receptors, Interleukin
3
2003
16
0.040
Why?
Risk
1
2020
320
0.040
Why?
Predictive Value of Tests
2
2012
875
0.040
Why?
United States
2
2018
3938
0.040
Why?
Postoperative Period
1
2018
97
0.040
Why?
Necrosis
1
2018
53
0.040
Why?
Transcriptional Activation
1
2018
42
0.040
Why?
Neoplasm Transplantation
1
2018
73
0.040
Why?
Longitudinal Studies
1
2020
766
0.040
Why?
Transplantation, Heterologous
1
2018
122
0.040
Why?
Avoidance Learning
1
2018
19
0.040
Why?
Neuronavigation
1
2017
8
0.040
Why?
Parvovirinae
1
2017
2
0.040
Why?
Hearing Tests
1
2017
13
0.040
Why?
Hospitalization
1
2020
470
0.040
Why?
Severity of Illness Index
1
2020
882
0.040
Why?
Confidence Intervals
1
2017
149
0.040
Why?
Gene Expression Regulation, Neoplastic
1
2018
261
0.030
Why?
Blood Gas Analysis
2
2008
17
0.030
Why?
Diffusion Tensor Imaging
1
2016
29
0.030
Why?
Biopsy
1
2017
259
0.030
Why?
Games, Experimental
1
2015
4
0.030
Why?
Positron-Emission Tomography
1
2017
163
0.030
Why?
DNA Modification Methylases
1
2015
11
0.030
Why?
DNA Repair Enzymes
1
2015
14
0.030
Why?
Electrodes, Implanted
1
2015
41
0.030
Why?
Cells, Cultured
2
2008
833
0.030
Why?
Spinal Cord
1
2016
130
0.030
Why?
Recovery of Function
1
2016
199
0.030
Why?
Tumor Suppressor Proteins
1
2015
71
0.030
Why?
Reoperation
1
2015
227
0.030
Why?
Action Potentials
1
2015
178
0.030
Why?
Levodopa
1
2014
14
0.030
Why?
Influenza A Virus, H3N2 Subtype
1
2014
23
0.030
Why?
Influenza B virus
1
2014
20
0.030
Why?
Dacarbazine
1
2014
29
0.030
Why?
Brain Stem
1
2014
20
0.030
Why?
Fetal Blood
2
2005
38
0.030
Why?
Models, Animal
1
2014
169
0.030
Why?
Receptors, Interleukin-13
2
2003
9
0.030
Why?
Interleukin-13 Receptor alpha1 Subunit
2
2003
10
0.030
Why?
Hemorrhage
1
2014
100
0.030
Why?
Models, Neurological
1
2014
117
0.030
Why?
Tumor Cells, Cultured
2
2003
170
0.030
Why?
Pain
1
2015
288
0.030
Why?
Carcinoma, Non-Small-Cell Lung
1
2014
101
0.030
Why?
Cost-Benefit Analysis
1
2013
185
0.030
Why?
Beta Rhythm
1
2012
1
0.030
Why?
Hypokinesia
1
2012
3
0.030
Why?
Antiparkinson Agents
1
2012
10
0.030
Why?
Embolization, Therapeutic
1
2013
87
0.030
Why?
Receptors, Progesterone
1
2012
72
0.030
Why?
Regression Analysis
1
2013
293
0.030
Why?
RNA, Messenger
2
2005
508
0.030
Why?
Receptors, Estrogen
1
2012
113
0.030
Why?
Pilot Projects
1
2014
543
0.030
Why?
Receptor, erbB-2
1
2012
65
0.030
Why?
Radiography
1
2013
376
0.030
Why?
Electric Stimulation
1
2012
104
0.030
Why?
Protein-Tyrosine Kinases
1
2012
40
0.030
Why?
Data Interpretation, Statistical
1
2012
109
0.030
Why?
Psychomotor Performance
1
2012
99
0.030
Why?
Radiometry
1
2012
40
0.030
Why?
Pain, Postoperative
1
2014
179
0.020
Why?
Reproducibility of Results
1
2014
762
0.020
Why?
Neuropsychological Tests
1
2013
371
0.020
Why?
Facial Paralysis
1
2011
7
0.020
Why?
Hydrocephalus
1
2011
12
0.020
Why?
Survivors
1
2013
164
0.020
Why?
Arthritis, Rheumatoid
1
2011
40
0.020
Why?
Otitis Media
1
2011
23
0.020
Why?
Pons
1
2010
6
0.020
Why?
Craniopharyngioma
1
2010
8
0.020
Why?
Spinal Nerve Roots
1
2010
14
0.020
Why?
Glial Fibrillary Acidic Protein
1
2010
41
0.020
Why?
Microtubule-Associated Proteins
1
2010
35
0.020
Why?
Pituitary Neoplasms
1
2010
17
0.020
Why?
Emaciation
1
2010
4
0.020
Why?
Medical Records
1
2010
76
0.020
Why?
Lupus Erythematosus, Systemic
1
2011
148
0.020
Why?
Gastroesophageal Reflux
1
2010
25
0.020
Why?
Essential Tremor
1
2010
12
0.020
Why?
Endoscopy
1
2010
58
0.020
Why?
Chi-Square Distribution
1
2010
297
0.020
Why?
Transplantation, Autologous
1
2009
80
0.020
Why?
Hydrogen-Ion Concentration
1
2008
66
0.020
Why?
Decompression, Surgical
1
2009
55
0.020
Why?
Injections, Intravenous
1
2008
78
0.020
Why?
Asthma
1
2010
259
0.020
Why?
O(6)-Methylguanine-DNA Methyltransferase
1
2007
1
0.020
Why?
Radioactivity
1
2006
2
0.020
Why?
Half-Life
1
2006
23
0.020
Why?
Infusions, Intravenous
1
2007
100
0.020
Why?
Body Weight
1
2008
310
0.020
Why?
Mental Disorders
1
2008
121
0.020
Why?
Adrenal Cortex
1
2005
3
0.020
Why?
Triiodothyronine
1
2004
7
0.020
Why?
Logistic Models
1
2007
781
0.020
Why?
Thyroxine
1
2004
16
0.020
Why?
Denervation
1
2004
13
0.020
Why?
Injections, Intralesional
1
2004
15
0.020
Why?
Viral Vaccines
1
2004
11
0.020
Why?
Adenovirus E1B Proteins
1
2004
19
0.020
Why?
Receptors, Angiotensin
1
2004
61
0.020
Why?
Virus Replication
1
2004
42
0.020
Why?
Gene Expression Regulation, Developmental
1
2004
69
0.020
Why?
Renin
1
2004
109
0.010
Why?
Inhibitory Concentration 50
1
2003
22
0.010
Why?
Pseudomonas
1
2003
6
0.010
Why?
Receptors, Interleukin-4
1
2003
6
0.010
Why?
Receptors, Transferrin
1
2003
10
0.010
Why?
Microscopy, Confocal
1
2003
65
0.010
Why?
Drug Synergism
1
2003
66
0.010
Why?
Drug Screening Assays, Antitumor
1
2003
58
0.010
Why?
Survival
1
2003
13
0.010
Why?
Receptors, Corticotropin-Releasing Hormone
1
2003
1
0.010
Why?
Maximum Tolerated Dose
1
2003
63
0.010
Why?
Receptors, Vasopressin
1
2003
7
0.010
Why?
Flow Cytometry
1
2003
185
0.010
Why?
Absorbable Implants
1
2003
24
0.010
Why?
Drug Resistance, Neoplasm
1
2003
104
0.010
Why?
Polymers
1
2003
64
0.010
Why?
Dose-Response Relationship, Drug
1
2004
632
0.010
Why?
Drug Therapy, Combination
1
2003
288
0.010
Why?
Seizures
1
2003
64
0.010
Why?
Clinical Trials as Topic
1
2004
301
0.010
Why?
Biocompatible Materials
1
2003
232
0.010
Why?
Gene Expression Regulation
1
2003
495
0.010
Why?
Tatter's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (375)
Explore
_
Co-Authors (52)
Explore
_
Similar People (51)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_